When platelet transfusions fail: refractoriness, explained
Learn more about what refractoriness is and why it can sometimes happen if a platelet transfusion is unsuccessful.
Learn more about what refractoriness is and why it can sometimes happen if a platelet transfusion is unsuccessful.
Find out how platelet transfusions for FNAIT are different from those used to treat other bleeding disorders.
Learn more about why testing a mother’s blood may not always be enough to detect FNAIT and what can be done to confirm a diagnosis.
Learn more about platelet glycoprotein and how it works to help form blood clots and stop bleeding in FNAIT.
Here’s what you should know about flow cytometry tests, which are often used to confirm a FNAIT diagnosis.
Learn more about the risks and benefits of intrauterine platelet transfusions for both mothers and infants.
Learn more about the difference between FNAIT caused by HPA-5b versus HPA-1a antibodies, including prevalence, disease severity and more.
Learn more about amniocentesis, an invasive procedure used to diagnose genetic, chromosomal or immune-related disorders like FNAIT.
Learn more about intrauterine platelet transfusions, including their risks, benefits and what patients can expect during the procedure.
Learn more about the difference between FNAIT caused by HPA-5b vs HPA-1a antibodies, including prevalence, treatment options and more.